The Fleming Fund Phase I: A Summary
The Fleming Fund's Phase I Report is now available.
The Phase I Report, titled 'The Fleming Fund Phase I: A Summary', showcases the achievements from the first phase of the programme. It also highlights some of the challenges faced when working in global AMR surveillance, and potential solutions to these problems.
We welcome you to share our Phase I Report with interested colleagues and networks. Once you have read it, we would be grateful if you could complete our feedback survey to help the Fleming Fund improve future publications.
The full document is available here
View pdf (3.68 MB)More Like This
Studies & Reports
From Studies & Reports, The Fleming Fund Phase I: A Summary - Accessible Version , Date: 26/04/2022
An accessible version of the Fleming Fund's Phase I Report is available here.
The Fleming Fund’s Regional Grants programme has been instrumental in tackling antimicrobial resistance (AMR) and addressing the acute impact in low- and middle-income countries (LMICs) where surveillance systems, laboratory capacity, and skilled workforces have historically been limited.